BioXclusters plus paves the way for precision medicine companies to China Market
On 15th – 16th May bioXclusters plus will carry out a China Mission, bringing clusters and companies together at the Sino European Bio Partnering (SEBP) event. Following bioXclusters plus strategy, the metacluster alliance will sign an MoU with Fenglin Group in order to provide guidance, consultancy and support to European life-sciences SMEs interested in doing business in China.
China is one of the fastest growing life science markets in the world. On the mission of bioXclusters plus to improve the internationalization of European personalized healthcare, bioXclusters plus organizes a companies and clusters mission to Shanghai, China, for the Sino European Bio Partnering (SEBP) conference. In addition to bioXclusters companies and Chinese companies, some companies from Switzerland, Austria, and the US will also participate the conference. Such events offer an opportunity to showcase life sciences innovation “Made in Europe” and to find matches and synergies among business partners beyond Europe.
Sino European Bio Partnering (SEBP) is one parallel event to CMEF, offering pre- selection, onsite support and follow up services for European and US participants for an efficient and long-lasting matchmaking. During the opening of the SEBP, an Agreement signing ceremony between Fenglin Group and bioXclusters plus will take place. This Gateway Agreement establishes that European companies receive a free consultancy package from Fenglin BioMedical Center to ease the European life-sciences SMEs entering the Chinese market or looking for business partners in China. The Agreement also offers the bioXclusters alliance, comprising of Biocat (Spain), BioM (Germany), BioPmed (Italy), Lyonbiopole (France) to become an entry point to Chinese companies aiming to get into the European Life Sciences market.
Interested European companies can contact Emilie ROMEO - bioXclusters Plus coordinator: [email protected]